BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 221 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,842,854 | +36.1% | 542,776 | +35.3% | 0.02% | +42.9% |
| Q2 2023 | $2,824,511 | -2.6% | 401,209 | +15.4% | 0.01% | -12.5% |
| Q1 2023 | $2,899,076 | +808.5% | 347,611 | +1150.6% | 0.02% | +700.0% |
| Q4 2022 | $319,098 | -78.8% | 27,796 | -69.9% | 0.00% | -71.4% |
| Q1 2022 | $1,503,000 | +96.7% | 92,430 | +91.2% | 0.01% | +75.0% |
| Q2 2021 | $764,000 | -37.6% | 48,352 | -92.1% | 0.00% | -63.6% |
| Q1 2020 | $1,224,000 | +100.0% | 611,934 | +244.8% | 0.01% | +175.0% |
| Q4 2019 | $612,000 | +684.6% | 177,482 | +992.0% | 0.00% | – |
| Q1 2018 | $78,000 | -57.6% | 16,253 | -56.7% | 0.00% | -100.0% |
| Q4 2017 | $184,000 | -28.1% | 37,528 | -23.2% | 0.00% | -50.0% |
| Q3 2017 | $256,000 | -32.3% | 48,855 | -63.3% | 0.00% | -33.3% |
| Q2 2016 | $378,000 | -33.7% | 133,005 | -34.0% | 0.00% | -25.0% |
| Q1 2016 | $570,000 | -73.3% | 201,573 | -2.4% | 0.00% | -77.8% |
| Q4 2015 | $2,132,000 | -21.5% | 206,573 | -13.3% | 0.02% | -18.2% |
| Q3 2015 | $2,716,000 | +101.0% | 238,273 | +163.3% | 0.02% | +83.3% |
| Q2 2015 | $1,351,000 | -6.8% | 90,498 | -43.6% | 0.01% | 0.0% |
| Q1 2015 | $1,450,000 | -44.0% | 160,598 | -24.6% | 0.01% | -42.9% |
| Q4 2014 | $2,591,000 | +56.4% | 213,098 | +25.8% | 0.02% | +61.5% |
| Q3 2014 | $1,657,000 | -18.3% | 169,398 | +13.4% | 0.01% | -7.1% |
| Q2 2014 | $2,029,000 | -67.1% | 149,398 | -71.7% | 0.01% | -68.9% |
| Q1 2014 | $6,167,000 | – | 528,098 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 7,637,700 | $77,675,000 | 7.44% |
| Burrage Capital Management LLC | 864,916 | $8,796,000 | 7.13% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,367,670 | $24,079,000 | 3.61% |
| HealthCor Management, L.P. | 4,886,440 | $49,695,000 | 1.76% |
| Ghost Tree Capital, LLC | 500,000 | $5,085,000 | 1.20% |
| Integral Health Asset Management, LLC | 400,000 | $4,068,000 | 1.16% |
| Lisanti Capital Growth, LLC | 472,520 | $4,806,000 | 0.62% |
| Parkman Healthcare Partners LLC | 244,680 | $2,488,000 | 0.58% |
| Baker Brothers Advisors | 12,710,818 | $129,269,000 | 0.56% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,605,380 | $26,497,000 | 0.56% |